Cabaletta Bio Inc
NASDAQ:CABA
Cabaletta Bio Inc
NASDAQ:CABA
Price:
12.875 USD
0.12%
Market Closed
Updated:
May 7, 2024
Cabaletta Bio Inc
Cash from Investing Activities
|
Cabaletta Bio Inc
Cash from Investing Activities Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Cabaletta Bio Inc
NASDAQ:CABA
|
Cash from Investing Activities
-$22.5m
|
CAGR 3-Years
-41%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Cash from Investing Activities
-$2B
|
CAGR 3-Years
62%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash from Investing Activities
-$2.3B
|
CAGR 3-Years
48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-76%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash from Investing Activities
-$27.8B
|
CAGR 3-Years
-72%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-10%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash from Investing Activities
-$3.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-73%
|
CAGR 10-Years
-50%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash from Investing Activities
-$4.6B
|
CAGR 3-Years
-89%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-26%
|
See Also
What is Cabaletta Bio Inc's Cash from Investing Activities?
Cash from Investing Activities
-22.5m
USD
-22.5m
USD
Based on the financial report for Dec 31, 2023, Cabaletta Bio Inc's Cash from Investing Activities amounts to -22.5m USD.
What is Cabaletta Bio Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
-41%
-41%
Over the last year, the Cash from Investing Activities growth was 18%. The average annual Cash from Investing Activities growth rates for Cabaletta Bio Inc have been -41% over the past three years .
You don't have any saved screeners yet
